Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Justice
Pharma
DOJ files motion to derail J&J's Texas two-step talc settlement
The U.S. Department of Justice has filed a motion to dismiss a J&J unit's Chapter 11 bid to settle more than 60,000 talc lawsuits in Texas.
Kevin Dunleavy
Oct 22, 2024 11:40am
Viatris, former president cleared in DOJ price-fixing probe
Jul 2, 2024 9:40am
Endo agrees to bankruptcy settlement with federal government
Feb 29, 2024 3:11pm
Viatris official Rayapureddy cleared of insider trading charges
Jan 30, 2024 8:30am
SEC charges a second Viatris exec in scheme that netted $7.2M
Nov 11, 2022 12:01pm
DOJ probes counterfeiting of HIV drugs from Gilead, GSK, J&J
Mar 31, 2022 9:44am
